Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

Coffee can cause symptoms like anxiety and jitteriness. Fortunately, you can enjoy other caffeinated and non-caffeinated ...

Metabolic Associated Fatty Liver Disease (MAFLD) has emerged as a global public health concern due to its increasing ...

This study shows that the SAAR diet regulates glucose and lipid metabolism to support weight control without impacting ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN ... FASCINATE-2, a Phase 2b clinical trial of denifanstat in MASH with liver biopsy-based primary ...

Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...

In a recent Fox News interview, the newly enshrined Health and Human Services secretary touted the benefits of supplements ...

Discover the 5 ways alcohol progressively harms your liver, from early warning signs to serious complications, plus expert ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase ... FASCINATE-2, a Phase 2b clinical trial of denifanstat in MASH with liver biopsy-based primary endpoints, ...